Apria Home
ChannelsResourcesServicesInsuranceBranch LocatorAbout ApriaCareersHelp
 resources
Community
Health Advisors
Patient Education
Other Sources
Glossaries
Product Manuals
FAQS
News
Electronic CMN
  Search Apria articles:
 
     
 Channels
Cancer
Caregivers
Degenerative Conditions
Diabetes
Heart
Infectious Diseases
Pediatrics
Respiratory
Seniors
Sleep Disorders
 
 
   
  Increase Font Size Decrease Font Size Printer Friendly
 
  Swedish parliament votes to end pharmacy monopoly by Jan 1 2009
 
 

STOCKHOLM (Thomson Financial) - Plans by Sweden's centre right government to end the 35 year monopoly of the state owned pharmaceutical retail chain Apoteket have been approved by Parliament.

"Parliament gave the government the green light to begin the restructuring process for Apoteket," it said in a statement.

The changes are expected to take effect by Jan 1, 2009.

The opposition Social Democrats, Left and Greens voted against the proposal.

Apoteket is currently the sole provider of prescription and non-prescription medication in Sweden, meaning that Swedes wanting to buy a headache tablet or other over-the-counter products must go to one of Apoteket's stores.

The government expects both domestic and international interest in the Swedish pharmacy market.

In a first step, the government will create a new parent company that will own all the shares in Apoteket and which will be in charge of selling a number of Apoteket's stores to private players. simon.richardson@thomsonreuters.com sjr/ra COPYRIGHT Copyright Thomson Financial News Limited 2008. All rights reserved. The copying, republication or redistribution of Thomson Financial News Content, including by framing or similar means, is expressly prohibited without the prior

 
  Copyright 2008 AFX News Limited. All Rights Reserved.
 
 
 
Contact Us | Terms & Conditions | Privacy Policy | HIPAA Privacy Notice
 
2007 Apria Healthcare All Rights Reserved.
No duplication of any material herein is authorized without the express consent of Apria Healthcare, Inc.
Please review the Terms and Conditions of this Web site.